Zhejiang Huahai Pharmaceutical Co Ltd (600521):企業の財務・戦略的SWOT分析

◆英語タイトル:Zhejiang Huahai Pharmaceutical Co Ltd (600521) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C12929
◆発行会社(調査会社):GlobalData
◆発行日:2019年1月
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Zhejiang Huahai Pharmaceutical Co Ltd (600521) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Zhejiang Huahai Pharmaceutical Co Ltd (Huahai Pharmaceuticals) is a pharmaceutical company that carries out the research, production and sale of formulations, active pharmaceutical ingredients (APIs) and pharmaceutical intermediates. The company also offers technology services. It provides pharmaceutical products in cardiovascular, central nervous system (CNS), metabolic disorders, infectious disease, women’s health and ophthalmology therapy areas. Huahai Pharmaceuticals has established domestic marketing network in compliance with GSP standards, with formulations covering several provinces and municipals of China. Operating through subsidiaries in the US and China, the company distributes its products to several countries worldwide. Huahai Pharmaceuticals is headquartered in Zhejiang, China.

Zhejiang Huahai Pharmaceutical Co Ltd Key Recent Developments

Dec 11,2018: FDA issues warning letter to Zhejiang Huahai Pharmaceutical involved in valsartan recall
Nov 29,2018: USFDA issues Warning Letter to Zhejiang Huahai Pharmaceutical
Oct 15,2018: EU authorities take further action in ongoing review of sartans: Zheijiang Huahai placed under increased supervision; Aurobindo Pharma stopped from supplying irbesartan to the EU Share
Oct 02,2018: Information update – Health Canada finds Zhejiang Huahai Pharmaceuticals site non-compliant with requirements for the manufacture of drug ingredients
Sep 13,2018: Update on review of valsartan medicines

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Zhejiang Huahai Pharmaceutical Co Ltd – Key Facts 5
Zhejiang Huahai Pharmaceutical Co Ltd – Key Employees 6
Zhejiang Huahai Pharmaceutical Co Ltd – Key Operational Employees 7
Zhejiang Huahai Pharmaceutical Co Ltd – Major Products and Services 8
Zhejiang Huahai Pharmaceutical Co Ltd – History 9
Zhejiang Huahai Pharmaceutical Co Ltd – Company Statement 10
Zhejiang Huahai Pharmaceutical Co Ltd – Locations And Subsidiaries 11
Head Office 11
Other Locations & Subsidiaries 11
Section 2 – Company Analysis 13
Company Overview 13
Zhejiang Huahai Pharmaceutical Co Ltd – Business Description 14
Zhejiang Huahai Pharmaceutical Co Ltd – Corporate Strategy 15
Zhejiang Huahai Pharmaceutical Co Ltd – SWOT Analysis 16
SWOT Analysis – Overview 16
Zhejiang Huahai Pharmaceutical Co Ltd – Strengths 16
Zhejiang Huahai Pharmaceutical Co Ltd – Weaknesses 17
Zhejiang Huahai Pharmaceutical Co Ltd – Opportunities 18
Zhejiang Huahai Pharmaceutical Co Ltd – Threats 19
Zhejiang Huahai Pharmaceutical Co Ltd – Key Competitors 20
Section 3 – Company Financial Ratios 21
Financial Ratios – Capital Market Ratios 21
Financial Ratios – Annual Ratios 22
Performance Chart 25
Financial Performance 25
Financial Ratios – Interim Ratios 26
Financial Ratios – Ratio Charts 27
Section 4 – Company’s Lifesciences Financial Deals and Alliances 28
Zhejiang Huahai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 28
Zhejiang Huahai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019 29
Zhejiang Huahai Pharmaceutical Co Ltd, Recent Deals Summary 30
Section 5 – Company’s Recent Developments 31
Dec 11, 2018: FDA issues warning letter to Zhejiang Huahai Pharmaceutical involved in valsartan recall 31
Nov 29, 2018: USFDA issues Warning Letter to Zhejiang Huahai Pharmaceutical 35
Oct 15, 2018: EU authorities take further action in ongoing review of sartans: Zheijiang Huahai placed under increased supervision; Aurobindo Pharma stopped from supplying irbesartan to the EU Share 36
Oct 02, 2018: Information update – Health Canada finds Zhejiang Huahai Pharmaceuticals site non-compliant with requirements for the manufacture of drug ingredients 37
Sep 13, 2018: Update on review of valsartan medicines 38
Section 6 – Appendix 39
Methodology 39
Ratio Definitions 39
About GlobalData 43
Contact Us 43
Disclaimer 43

List of Tables
Zhejiang Huahai Pharmaceutical Co Ltd, Key Facts 5
Zhejiang Huahai Pharmaceutical Co Ltd, Key Employees 6
Zhejiang Huahai Pharmaceutical Co Ltd, Key Operational Employees 7
Zhejiang Huahai Pharmaceutical Co Ltd, Major Products and Services 8
Zhejiang Huahai Pharmaceutical Co Ltd, History 9
Zhejiang Huahai Pharmaceutical Co Ltd, Subsidiaries 11
Zhejiang Huahai Pharmaceutical Co Ltd, Key Competitors 20
Zhejiang Huahai Pharmaceutical Co Ltd, Ratios based on current share price 21
Zhejiang Huahai Pharmaceutical Co Ltd, Annual Ratios 22
Zhejiang Huahai Pharmaceutical Co Ltd, Annual Ratios (Cont...1) 23
Zhejiang Huahai Pharmaceutical Co Ltd, Annual Ratios (Cont...2) 24
Zhejiang Huahai Pharmaceutical Co Ltd, Interim Ratios 26
Zhejiang Huahai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 28
Zhejiang Huahai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019 29
Zhejiang Huahai Pharmaceutical Co Ltd, Recent Deals Summary 30
Currency Codes 39
Capital Market Ratios 39
Equity Ratios 40
Profitability Ratios 40
Cost Ratios 41
Liquidity Ratios 41
Leverage Ratios 42
Efficiency Ratios 42

List of Figures
Zhejiang Huahai Pharmaceutical Co Ltd, Performance Chart (2013 - 2017) 25
Zhejiang Huahai Pharmaceutical Co Ltd, Ratio Charts 27
Zhejiang Huahai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 28
Zhejiang Huahai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019 29

★海外企業調査レポート[Zhejiang Huahai Pharmaceutical Co Ltd (600521):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Banner Health-製薬・医療分野:企業M&A・提携分析
    Summary Banner Health (Banner) is a nonprofit health care system that offers hospital care, hospice care, nursing registries, surgery center, laboratories and rehabilitation services. It also provides community-based social service programs and health-related educational programs. The organization o …
  • Ambac Financial Group, Inc.:企業の戦略・SWOT・財務分析
    Ambac Financial Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Ambac Financial Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • EnergySolutions, LLC-エネルギー分野:企業M&A・提携分析
    Summary EnergySolutions, LLC (EnergySolutions) is a nuclear services company that provides integrated services and solutions for management of radioactive material. It offers nuclear operations; characterization; decommissioning; decontamination; site closure; transportation; nuclear materials manag …
  • Tampa Electric Co-エネルギー分野:企業M&A・提携分析
    Summary Tampa Electric Company (TEC), a subsidiary of Emera Inc., is an energy utility. It conducts the generation, purchase, transmission, distribution and sale of electricity and the distribution, purchase and sale of natural gas in Florida. The service area for electric operations covers West Cen …
  • Webjet Limited:企業の戦略・SWOT・財務情報
    Webjet Limited - Strategy, SWOT and Corporate Finance Report Summary Webjet Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • BioNano Genomics Inc:医療機器:M&Aディール及び事業提携情報
    Summary BioNano Genomics Inc (BioNano) is a developer of technology platform to analyze the segments of genomic DNA and other structural variations. The company's products include irys chip, saphyr, genome mapping systems and prep kits. Its saphyr offers breakthrough speed and throughput with unmatc …
  • William Demant Holding AS (WDH)-医療機器分野:企業M&A・提携分析
    Summary William Demant Holding A/S (WDH) develops, manufactures and distributes products and equipment designed to aid people with hearing loss in their individual communication. Its major areas of focus include hearing devices, hearing implants, diagnostic instruments and personal communication dev …
  • Centene Corp (CNC):企業の財務・戦略的SWOT分析
    Centene Corp (CNC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Macquarie Group Ltd:戦略・SWOT・企業財務分析
    Macquarie Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Macquarie Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • European Investment Bank:企業の戦略的SWOT分析
    European Investment Bank - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Kyowa Hakko Kirin Co., Ltd.:企業のM&A・事業提携・投資動向
    Kyowa Hakko Kirin Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Kyowa Hakko Kirin Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Telecom Plus plc (TEP)-エネルギー分野:企業M&A・提携分析
    Summary Telecom Plus plc (Telecom Plus), trading as The Utility Warehouse, is a provider of utility services. The company provides diversified utility services, including fixed and mobile telephony, gas, electricity, cashback card services and broadband services. It provides benefit of single monthl …
  • Etihad Airways:企業のM&A・事業提携・投資動向
    Etihad Airways - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Etihad Airways Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Innocoll AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Innocoll AG (Innocoll), formerly Innocoll Holdings Plc is a pharmaceutical company that carries out the development and manufacturing of surgical implants and topically applied healthcare products in the areas of unmet clinical needs. The company’s pipeline product Xaracoll, a bupivacaine HC …
  • Alexza Pharmaceuticals Inc:医療機器:M&Aディール及び事業提携情報
    Summary Alexza Pharmaceuticals Inc (Alexza), a wholly owned subsidiary of Ferrer Therapeutics Inc, focuses on the research, development and commercialization of novel, proprietary products for the treatment of acute central nervous system diseases. The company develops all its products based on its …
  • Clinical Innovations LLC-医療機器分野:企業M&A・提携分析
    Summary Clinical Innovations LLC (Clinical Innovations), a subsidiary of Pritzker Group Company is a medical device company that offers healthcare products for women and infants. The company offers products such as safety heelsticks, traxi panniculus retractor, ROM plus membrane testing, tamponade s …
  • American Blue Ribbon Holdings LLC:企業の戦略・SWOT・財務分析
    American Blue Ribbon Holdings LLC - Strategy, SWOT and Corporate Finance Report Summary American Blue Ribbon Holdings LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Celldex Therapeutics Inc (CLDX):製薬・医療:M&Aディール及び事業提携情報
    Summary Celldex Therapeutics Inc (Celldex) is a bio-pharmaceutical company that discovers, develops and commercializes targeted immunotherapy technologies and cancer-targeting biologicsfor the treatment of various types of cancers. The company’s developmental pipeline comprises therapeutic antibodie …
  • Aleva Neurotherapeutics SA:医療機器:M&Aディール及び事業提携情報
    Summary Aleva Neurotherapeutics SA (Aleva) is a medical device company that provides neuro-stimulation solutions. The company’s products include deep brain stimulation diagnostic systems and deep brain stimulation systems. Its deep brain stimulation systems provide directional stimulation for more p …
  • Vitrolife AB (VITR):医療機器:M&Aディール及び事業提携情報
    Summary Vitrolife AB (Vitrolife) is a developer, producer and marketer of laboratory products. The company provides products such as follicle aspiration needles, sperm processing, culture media, culture oil, additional culture media, micromanipulation solutions, vitrolife labware, micromanipulation …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆